Hyderabad: The Drugs Controller General of India (DGCI) has given permission to Bharat Biotech to test its COVID-19 vaccine, COVAXIN, by administering it via the skin.
This intradermal vaccine delivery route is less invasive and will require a lesser dosage as well. The inactive virus-based vaccine is also being tested to be delivered in the intramuscular way.
Currently, the indigenously built vaccine is in phase II trials.
Kataka: Odisha’s Sushree Dibyadarshini has been named in the India A squad for the multi-day match against Australia A during...
Bhubaneswar: The India Meteorological Department (IMD) has issued a nowcast warning for seven districts of Odisha, including twin cities of...
Chennai: Odisha’s Rutaparna and Swetaparna Panda were at their best in the Yonex-Sunrise All India Senior Ranking Badminton tournament in...
Cuttack: Odisha cricketer Sushree Dibyadarshini has been selected by the All-India Women’s Selection Committee to participate in the Targeted Women’s...
Copyright © 2026 Frontier Media
